Immuneering (IMRX) EBITDA Margin (2020 - 2022)
Immuneering's (IMRX) quarterly EBITDA Margin came in at 3073627.91% in Q4 2022, down 306776489.0% year-on-year from N/an in Q4 2021, and down 8844.84% quarter-over-quarter from 34362.04% in Q3 2022.
Immuneering (IMRX) EBITDA Margin (2020 - 2022) Analysis & Trends
Immuneering's EBITDA Margin history runs 3 years deep, the most recent figure standing at 3073627.91% for Q4 2022.
- On a quarterly basis, EBITDA Margin fell 306776489.0% year-over-year to 3073627.91% in Q4 2022; TTM through Sep 2023 was 12328770.77%, a 1231911324.0% decrease from a year earlier, with the FY2022 full-year figure at 16325.77%, down 1469661.0% from the prior year.
- EBITDA Margin slipped to 3073627.91% in Q4 2022 per IMRX's latest filing, from 34362.04% in the prior quarter.
- Across five years, EBITDA Margin topped out at 644.66% in Q3 2020 and bottomed at 3073627.91% in Q4 2022.
- The 3-year median for EBITDA Margin is 1772.01% (2021), against an average of 285392.02%.
- Across the five-year window, EBITDA Margin sank 46060 bps in 2021 and tumbled 306776489 bps in 2022, its largest moves.
- Year by year, EBITDA Margin stood at 877.56% in 2020, then tumbled by 568 bps to 5863.02% in 2021, then slumped by 52324 bps to 3073627.91% in 2022.
- Per Business Quant, the three latest IMRX EBITDA Margin figures stand at 3073627.91% (Q4 2022), 34362.04% (Q3 2022), and 12334.43% (Q2 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 16.51% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 30.35% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immuneering | 279.33 Mn | 279.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -3,073,627.91% |
| Sep 30, 2022 | -34,362.04% |
| Jun 30, 2022 | -12,334.43% |
| Mar 31, 2022 | -7,036.37% |
| Dec 31, 2021 | -5,863.02% |
| Sep 30, 2021 | -1,772.01% |
| Jun 30, 2021 | -1,210.67% |
| Mar 31, 2021 | -833.47% |
| Dec 31, 2020 | -877.56% |
| Sep 30, 2020 | -644.66% |
| Jun 30, 2020 | -750.08% |